Sreeram Kannan
Assistant Professor @ University of Washington
San Diego, United States
Sreeram Kannan is a seed investor at University of Washington in San Diego focused on Blockchain and Cryptocurrency. Sreeram Kannan is the CEO of EigenLayer.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Sreeram Kannan invests in
Stages Sreeram Kannan invests in
Countries Sreeram Kannan invests in
Round sizes
Round size
- Seed
- $5.5M–$25M
- Pre-Seed
- $4M–$6M
- Series A
- $12M–$55M
Investment Focus
Industry
- Blockchain 11 (48%)
- Cryptocurrency 5 (22%)
- Ethereum 3 (13%)
- Software 3 (13%)
- Information Technology 3 (13%)
Stage
- Seed 14 (61%)
- Series A 4 (17%)
- Pre-Seed 2 (9%)
- Funding Round 1 (4%)
- Post-IPO Equity 1 (4%)
Country
- United States 10 (43%)
- Singapore 2 (9%)
- Argentina 1 (4%)
- United Kingdom 1 (4%)
- The Netherlands 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Nava labs is the developer of AI control infrastructure designed to verify and secure the execution of AI agents in financial environments. | $8.3M / Seed / Apr 14, 2026 | |
|
|
Self is spearheading a secure, human-first internet by allowing users to verify their identities while maintaining their privacy. Self Protocol is an identity and proof-of-humanity solution that uses zero-knowledge technology to confirm personhood and distinctive traits, like age and nationality, without revealing private information. | $9M / Seed / Nov 13, 2025 | |
|
|
ScaleIP is an IP business intelligence platform that helps companies monetize IP. | $4M / Pre-Seed / Nov 05, 2025 | |
|
|
GRVT is an institutional-grade self-custody derivatives trading platform, where we eliminate counterparty risk and offer unparalleled efficiency. With features like KYC, self-custody, and privacy-enabled trading, plus high transaction throughput, we provide RFQ and CLOB options for futures, perpetuals, and more. | $19M / Series A / Sep 18, 2025 | |
|
|
180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University, and Stanford University. | $425M / Post-IPO Equity / Jul 29, 2025 | |
|
|
Miden grants applications the power to scale with public and private transactions. | $25M / Seed / Apr 29, 2025 | |
|
|
Warlock Labs is a provider of an omni-chain liquidation engine that improves the safety and profitability of decentralized protocols by recapturing the maximum extractable value. | $8M / Seed / Mar 27, 2025 | |
|
|
Commonware is a startup that supplies developers with a "anti-framework" — effectively all of the building pieces for developing a blockchain — in order to go beyond the era of standardized, general-purpose software kits. | $9M / Dec 11, 2024 | |
|
|
Hyperbolic is the open-access AI cloud made for AI developers, providing fast, affordable access to compute, inference, and AI services. | $12M / Series A / Dec 10, 2024 | |
|
|
Ethereum is the settlement layer, build full stack decentralized apps on top with Web Assembly and the EVM. | $6M / Seed / Oct 03, 2024 | |
| See all 23 investments → | |||
Co-Investors
About University of Washington
The University of Washington is an educational institution that provides undergraduate, graduate, and research programs.The institution offers courses in business, social sciences, science, law, medicine, public affairs, and many other subjects. The schools of the university include the College of Engineering, School of Dentistry, College ofArchitecture and Urban Planning, School of Pharmacy, School of Public Health and Community Medicine, School of Business, School of Humanities and Sciences, School of Law, School of Nursing, College of Ocean and Fishery Sciences, and School of Medicine.The University of Washington was founded in 1861 and is based in Seattle, Washington.
University of Washington Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Arthur Denny
Founder
|
|||
|
Bryan Comstock
Senior Biostatistician
|
|||
|
Crystal Eney
Director of Student Services/Academic Advisor - Lead
|
|||
|
Dan Weld
WRT / TJ Cable Professor
|
|||
|
David Ginger
Associate Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sreeram Kannan invest in?
Sreeram Kannan invests primarily in Blockchain, Cryptocurrency and Ethereum startups, most often at Seed and Series A stage. Most of the 23 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Sreeram Kannan's check size?
Sreeram Kannan typically joins rounds of $5.5M–$25M at Seed, $4M–$6M at Pre-Seed and $12M–$55M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sreeram Kannan participates in.
When did Sreeram Kannan last invest?
The most recent investment recorded for Sreeram Kannan closed in Apr 2026. Shizune tracks 23 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!